These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


680 related items for PubMed ID: 16167966

  • 1. Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
    Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C.
    Aliment Pharmacol Ther; 2005 Sep 15; 22(6):495-512. PubMed ID: 16167966
    [Abstract] [Full Text] [Related]

  • 2. Probiotics, prebiotics, and synbiotics.
    de Vrese M, Schrezenmeir J.
    Adv Biochem Eng Biotechnol; 2008 Sep 15; 111():1-66. PubMed ID: 18461293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E, Stavropoulou E.
    Anaerobe; 2011 Dec 15; 17(6):369-74. PubMed ID: 21515397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application.
    Cheikhyoussef A, Pogori N, Chen W, Zhang H.
    Int J Food Microbiol; 2008 Jul 31; 125(3):215-22. PubMed ID: 18514343
    [Abstract] [Full Text] [Related]

  • 11. In vitro assessment of the gastrointestinal transit tolerance of taxonomic reference strains from human origin and probiotic product isolates of Bifidobacterium.
    Masco L, Crockaert C, Van Hoorde K, Swings J, Huys G.
    J Dairy Sci; 2007 Aug 31; 90(8):3572-8. PubMed ID: 17638965
    [Abstract] [Full Text] [Related]

  • 12. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M.
    J Appl Microbiol; 2006 Jun 31; 100(6):1324-32. PubMed ID: 16696680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Probiotic therapy of intestinal inflammation and infections.
    Sartor RB.
    Curr Opin Gastroenterol; 2005 Jan 31; 21(1):44-50. PubMed ID: 15687884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium.
    Meile L, Le Blay G, Thierry A.
    Int J Food Microbiol; 2008 Sep 01; 126(3):316-20. PubMed ID: 17889391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Probiotics in the new millennium.
    Vaughan EE, Mollet B.
    Nahrung; 1999 Jun 01; 43(3):148-53. PubMed ID: 10399346
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.